AzTrials
AzTrials

Rib Fracture MultipleNCT05758870

A Prospective Randomized Controlled Study Comparing the Clinical Effects of Surgical and Non-surgical Treatment of Low Rib Fractures

An observational study of Rib Fracture Multiple, run by Shanghai Jiao Tong University Affiliated Sixth People's Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to explore the difference between the clinical effects of surgical and non-surgical treatment for patients with low rib fracture, and to explore whether SSRF has more clinical treatment advantages in patients with low rib fracture in a randomized, controlled and prospective manner. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Rib Fracture Multiple
What is being tested?
surgical stabilization of low rib fratures and converstive treatment of low rib fratures
Type of treatment
Surgery or procedure
How many people
64 participants
Where
No sites listed yet
Study dates
1 Apr 2023to 31 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patient with multiple rib fractures combines with low rib fractures

Who may be able to join

  • Patients with chest trauma only and unilateral low rib fractures Three rib fractures and more Displacement of the broken end of the fracture (bicortical fracture and not in the same line) Time from injury to hospital < 24 hours Age 18-70 ASA grade I-II Preoperative arterial oxygen partial pressure >60mmHg, carbon dioxide partial pressure <50mmHg The participate is volunteer in the study and sign the informed consent Pain score( Number Rating Scale, NRS) >5 under calm breathing

Who cannot join

  • Difficult airway History of esophageal reflux Myasthenia gravis Coagulation disorders Gastrointestinal ulcer Gastrointestinal bleeding Anesthetic drugs allergy history Asthma Chronic obstructive pulmonary disease Pregnant women

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

The purpose of this study is to explore the difference between the clinical effects of surgical and non-surgical treatment for patients with low rib fracture, and to explore whether SSRF has more clinical treatment advantages in patients with low rib fracture in a randomized, controlled and prospective manner.

Being tested
surgical stabilization of low rib fratures, converstive treatment of low rib fratures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • surgical stabilization of low rib fraturesProcedure or surgery

    surgical stabiliazation of rib fractures by internal fixation

  • converstive treatment of low rib fraturesOther

    chest wall fixation band

Study groups in NCT05758870
Study groupRoleWhat they receive
Research Groupsurgical stabilization of low rib fracures by internal fixation
Receives: Procedure: surgical stabilization of low rib fratures
Controls Groupconservative treatment of low rib fractures
Receives: Other: converstive treatment of low rib fratures

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. EQ-5D-5L

    appraisal of life quality

    Measured: On the day of admission

  2. EQ-5D-5L

    appraisal of life quality

    Measured: 1 week after treatment

  3. EQ-5D-5L

    appraisal of life quality

    Measured: 2 weeks after treatment

  4. EQ-5D-5L

    appraisal of life quality

    Measured: 1 month after treatment

  5. EQ-5D-5L

    appraisal of life quality

    Measured: 3 months after treatment

  6. EQ-5D-5L

    appraisal of life quality

    Measured: 6 months after treatment

Secondary outcomes (6)
  1. Pain Score

    Number Rating Score, NRS

    Measured: On the day of admission

  2. Pain Score

    Number Rating Score, NRS

    Measured: 1 week after treatment

  3. Pain Score

    Number Rating Score, NRS

    Measured: 2 weeks after treanment

  4. Pain Score

    Number Rating Score, NRS

    Measured: 1 month after treatment

  5. Pain Score

    Number Rating Score, NRS

    Measured: 3 months after treatment

  6. Pain Score

    Number Rating Score, NRS

    Measured: 6 months after treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Mar 2023
  2. Study start1 Apr 2023 (estimated)
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05758870
Sponsor's protocol ID
20220815
Status last verified
Feb 2023
First submitted
11 Feb 2023
Last updated
8 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Rib Fracture Multiple, run by Shanghai Jiao Tong University Affiliated Sixth People's Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Weiming Wu (18930172451, wuweiming0427@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

EQ-5D-5L (time frame: On the day of admission). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in